Savonix, a San Francisco, CA-based cognitive health company, completed a $9.6M Series A extension financing.
The round, which brought total funding to date to $14.7M, was co-led by new investors Fusion Fund and Wavemaker Partners (Draper Venture Network), with participation from DEFTA Partners and existing investors Rethink Impact and DigiTx Partners. In conjunction with the new financing, Lu Zhang, Founder and Managing Partner at Fusion Fund, BT Slingsby, CEO & Executive Director at Global Health Innovative Technology Fund, and Tony Estrella, Managing Director of Taliossa will join Savonix’s Board of Directors.
The company intends to use the funds to accelerate continued growth and market expansion for its cognitive platform into key markets in the US and Asia.
Led by Dr. Mylea Charvat, CEO and Founder, Savonix leverages machine learning to gather insights from data to drive population health knowledge about cognition and its relationship to biomarkers and diseases as diverse as diabetes and dementia. The company’s flagship digital cognitive assessment platform, Savonix Mobile, delivers an actionable mobile assessment of brain health.